- CA$4.32m
- CA$14.47m
- $5.51m
- 16
- 97
- 22
- 42
Annual income statement for ARCpoint, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 19.2 | 10.9 | 6.67 | 5.51 |
Cost of Revenue | ||||
Gross Profit | 12.9 | 5.91 | 1.79 | 3.4 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 13.5 | 18.5 | 15.4 | 3.67 |
Operating Profit | 5.66 | -7.62 | -8.72 | 1.83 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 5.72 | -8.32 | -9.15 | 1.13 |
Provision for Income Taxes | ||||
Net Income After Taxes | 5.72 | -8.32 | -8.94 | 1.35 |
Minority Interest | ||||
Net Income Before Extraordinary Items | ||||
Net Income | 5.73 | -8.04 | -8.66 | 1.36 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Dilution Adjustment | ||||
Diluted Net Income | 5.77 | -8.04 | -8.66 | 1.36 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 36.3 | -0.071 | -0.092 | -0.023 |